RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis

RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis

Saved in:

Bibliographic Details
Main Authors:	Huiguang Xue, Aihua Yang, Fuguo Liu, Xueguo Sun, Xishuang Liu
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-06-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/2058739218781291
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
by: Hongzhang Shen, et al.
Published: (2021-01-01)

A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels
by: Sun-Young Lee, et al.
Published: (2025-07-01)

The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study
by: Tianyi Zhang, et al.
Published: (2025-06-01)

Serum Gastrin and Pepsinogen Levels after Administration of Acid Secretion Inhibitors for Ulcers due to Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer
by: Maidina Abuduwaili, et al.
Published: (2022-01-01)

High Prevalence of Serum Immunoglobulin G Antibody to Helicobacter pylori and Raised Serum Gastrin and Pepsinogen Levels in Enlarged Fold Gastritis
by: Yuichi Yasunaga, et al.
Published: (1997-01-01)

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer
by: Yanfang Wang, et al.
Published: (2025-01-01)

Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
by: Ya-kai Huang, et al.
Published: (2015-01-01)

Cost-Effectiveness of Serum Pepsinogen as a Gastric Cancer Targeted Screening Strategy in the United States
by: Aaron Oh, et al.
Published: (2025-01-01)

Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen
by: Hyun Seok Lee, et al.
Published: (2018-01-01)

Integrated analysis of myeloperoxidase in gastric health and cancer: associations with pepsinogen levels, immune regulation, and prognosis in a large healthy population-based and TCGA cohorts
by: Junteng Zhou, et al.
Published: (2025-06-01)

Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases
by: Jingyi Jiang, et al.
Published: (2018-08-01)

Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.
by: Teruhiko Terasawa, et al.
Published: (2014-01-01)

Gastrin‐Releasing Peptide Facilitates Cholinergically Mediated Contractions of the Mouse Gastric Fundus
by: Diego Currò, et al.
Published: (2025-08-01)

Helicobacter pylori infection and serum pepsinogen concentrations in an elderly population representative of Costa Rica
by: Clas Une, et al.
Published: (2022-01-01)

Positive Correlation between Normal Serum Gastrin Concentrations and Antral and Duodenal G Cells
by: WR Yacoub, et al.
Published: (1994-01-01)

The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis
by: Ling Liu, et al.
Published: (2019-01-01)

Pepsinogen I as a marker of risk of gastric mucosal cell destruction in Helicobacter pylori-infected patients taking acetylsalicylic acid
by: I.G. Paliy, et al.
Published: (2025-06-01)

Antral Gastrin Cell Hyperfunction Associated with Chronic Pancreatitis
by: Atilla Ertan, et al.
Published: (1988-01-01)

In vitro gastrin-releasing peptide response in chicken ovarian follicles
by: Chunheng Mo, et al.
Published: (2025-08-01)

Diarrhea, Weight Loss, and an Elevated Gastrin: A Case Report
by: Ryan G. Alexander, et al.
Published: (2025-06-01)

Precision Theranostics in Nuclear Medicine Targeting Gastrin-Releasing Peptide Receptor
by: WANG Rongxi, et al.
Published: (2025-07-01)

The dynamics of pepsinogens plasma levels in cardiosurgical patients with erosive and ulcerous changes of the gastroduodenal area
by: Ye. A. Sorokina, et al.
Published: (2012-12-01)

Gastrin-releasing peptide is essential for generalization of auditory conditioned fear under stress
by: Yi Wu, et al.
Published: (2025-05-01)

Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints
by: Ze-Rong Cai, et al.
Published: (2024-11-01)

Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis
by: Jinjuan Fu, et al.
Published: (2021-08-01)

RETRACTED: The expression and clinical significance of PDCD4 and Her-2 in human gastric cancer
by: Yuelou Yang, et al.
Published: (2019-03-01)

Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms
by: Achim Fleischmann, et al.
Published: (2007-01-01)

Correction: Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis
by: Jinjuan Fu, et al.
Published: (2025-05-01)

Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors
by: Maarten Brom, et al.
Published: (2011-03-01)

Significance of Decreased Serum High-density Lipoprotein Cholesterol Levels in Patients with Gastric Cancer
by: Tae Ho Kim
Published: (2022-09-01)

Identification and validation of serum MUC17 as a non‐invasive early warning biomarker for screening of gastric intraepithelial neoplasia
by: Bingxue Yang, et al.
Published: (2025-01-01)

Editorial: From bench to bedside in gastric cancer: diagnosis, prognosis, and treatment, volume II
by: Avtar Singh Meena, et al.
Published: (2025-03-01)

Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients
by: Li Xiang, et al.
Published: (2022-01-01)

Gastrin-releasing peptide receptor: a promising new biomarker to identify cervical precursor lesions and cancer
by: Martina Lichtenfels, et al.
Published: (2025-03-01)

Preoperative Localization of a Gastrin-Secreting Tumour by Total Body Imaging with 111Indium-Labelled Pentatreotide
by: Humera Ali, et al.
Published: (1994-01-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

Streptococcus lutetiensis inhibits CD8+ IL17A+ TRM cells and leads to gastric cancer progression and poor prognosis
by: Huiyu Wang, et al.
Published: (2025-02-01)

Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer
by: Yuki Hirase, et al.
Published: (2025-05-01)

Rehabilitation Training Can Significantly Increase the Serum IL-11 Levels and Improve the Prognosis in Ischemic Stroke Patients
by: Xiaoliu Li, et al.
Published: (2023-01-01)

RETRACTED: Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma
by: Chao Xiang, et al.
Published: (2018-10-01)